Fast dissolving drug delivery system: Innovative strategies for drug application
Keywords:
disintegrating tablets, Direct compression, Disintegration time, Super?DisintegrantsAbstract
Fast disintegrating tablets (FDTs) have received ever-increasing demand during thelast decade, and the field has become a rapidly growing area in the pharmaceuticalindustry. Oral drug delivery remains the preferred route for administration of various drugs. Recent developments in the technology have prompted scientists to develop FDTs with improved patient compliance and convenience. Upon introduction into themouth, these tablets dissolve in the mouth in the absence of additionalwater for easy administration of active pharmaceutical ingredients. The popularity andusefulness of the formulation resulted in development of several FDT technologies. Particularly for pediatric and geriatric populations who have difficulty in swallowing conventional tablets and capsules. This review describes various formulations and technologies developed to achieve fast dissolution/dispersion of tablets in the oral cavity. In particular recent development in fast disintegrating technology mainly works to improve the disintegration quality of these delicate dosage forms without affecting their integrity. This article focuses on the patented technologies available and the advances made so far in the field of fabrication of fast disintegrating tablets. Apart from the conventional methods of fabrication, this review also provides the detailed concept of some unique technologies like freeze drying, direct compression, spray drying, tablet molding, sublimation fast dissolving films cotton candy process, along with their advantages and limitations.
Downloads
References
Slowson, M., Slowson, S., What to do when patients cannotswallow their medications,Pharm. Times, 51, 90?96,(1985)
Seager, H., Drug?deliver Products and the Zydis Fast?dissolvingDosage Form, J. Pharm. and Pharmacol., 50, 375?382(1993)
Habib, W., Khankari, R., Hontz, J., 2000, Fast?dissolving drugdelivery systems, critical review in therapeutics, Drug CarrierSystems, 17(1):61?72.
PebleyWalter S., Jager,Norman E. Thompson Sally J. Rapidlydistintegrating tablet , United States Patent 5298261,(1994)
A.C. Liang and L.I.H. Chen, Expert Opin. Ther.Pat., 11,981 (2001).
H. Seager, J. Pharm. Pharmacol., 50, 375 (1998).
D.G. Yu, X.X. Shen, C. Branford-White, K. White, L.M.Zhu, and S.W. Annie Bligh, Nanotechnology., 20, 55104(2009).
S. Baboota, A. Ahuja, and J. Ali, Expert Opin. Ther. Pat.,18, 769 (2008).
S.S. Biradar, S.T. Bhagavati, and I.J. Kuppasad, Internet J.Pharmacol., 4, (2006).
Q. Jing, Y. Yang, C. Branford-White, et al., Colloid Surface.B., 88, 304 (2011).
D. Bhowmik, B. Chiranjib, R.J. Margret Chandira, Chem. Pharm. Res, 1(1), 163-177(2009)
European Directorate for quality of Medicines. Pharmaeuropa.10(4):547;(1998)
Guptha.A, Mishra AK, Guptha .v, Bansal P, Singh R, Singh AK. Recent Trends of Fast Dissolving Tablets-Review.int J Pharm Bio Arch (1):1-10;(2010)
Chang, R., Guo, X., Burnside, B. A. , Couch, R., Fast dissolving tablets, Pharm. Tech., 24(6):52?58.(2000)
Panigrahi D, Baghel S, Mishra B. Mouth dissolving tablets: an overview of preparation techniques, evaluation and patented technologies. J Pharm Res. 4(3): 33-38?(2005)
US FDA. Guidance for industry: orally disintegrating tablets [monograph on the internet]. Silver Spring, MD: US Food and Drug Administration;[cited 2010 Aug 12]. Available from:http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070578.pdf(2008)
Vikas A, Bhavesh HK, Derek VM, Rajendra KK. Drug delivery: Fast dissolve systems. Encycl Phar Tech1:1104-14;(2007)
Jinichi F, Etsuo Y, Yasuo Y, Katsuhide T. Evaluation of rapidly disintegrating tablets containing glycine and carboxymethylcellulose. Inter J Pharm 310:101-109(;2017)
Segar H. Drug delivery products and the Zydis fast dissolving dosage. J Pharm Pharmacol;50:375-83(1998)
Corveleyn S, Remon J. Formulation of a lyophilised dry emulsion tablet for the delivery of poorly soluble drugs. Int J Pharm 166:65-74.(1998)
Chandrasekhar R, Hassan Z, AlHusban F, Smith A, Mohammed A. The role of formulation excipients in the development of lyophilized fast-disintegrating tablets. Eur J Pharm Biopharm 72:119-29.(2009)
Carstensen JT. Pharmaceutics of Solids and Solid Dosage Forms,New York: Wiley Interscience; 1977. p.11-5.
Van Campen L, Zografi G, Carstensen JT. An approach to theevaluation of hygroscopicity for pharmaceutical solids.Int J Pharm5:1-18(1980)
Chang RK, Guo X, Burnside BA, Couch RA.Fast-dissolving tablets.Pharm Technol N Am 24:52-8(2000)
Jinichi F, Etsuo Y, Yasuo Y, Katsuhide T. Evaluation of rapidly disintegrating tablets containing glycine and carboxymethylcellulose. Inter J Pharm 310:101-109(2006)
Segar H. Drug delivery products and the Zydis fast dissolving dosage. J Pharm Pharmacol 1998;50:375-83.
Corveleyn S, Remon J. Formulation of a lyophilised dry emulsion tablet for the delivery of poorly soluble drugs. Int J Pharm 166:65-74.(1998)
Chandrasekhar R, Hassan Z, AlHusban F, Smith A, Mohammed A. The role of formulation excipients in the development of lyophilized fast-disintegrating tablets. Eur J Pharm Biopharm;72:119-29.(2009)
Blank RG, Mody DS, Kenny RJ, Aveson MC. Fast dissolving dosage form. US Patent 4,946,684, Aug 7, (1990)
Green R, Kearney P. Process for preparing fast dispersing solid dosage form. US Patent 5,976,577,Nov 2, (1999)
Lawrence J, Posage G. Bicovex rapidly disintegrating dosage form. US Patent 6,224,905, Dec 3, (1998)
Simone S, Peter CS. Fast dispersing ibuprofen tablets. Eur J Pharm Sci;15:295-305.(2002)
Laitinen R, Suihko E, Toukola K, Bjorkqvist M, Riikonen J, Lehto VP, Jarvinen K, Ketolainen J. Intraorally fast-dissolving particles of a poorly soluble drug: Preparation and in vitro characterization. Eur J Pharm Biopharm.71: 271-281.(2009)
Modi A, Tayade P. Enhancement of dissolution profile by solid dispersion (kneading) technique. AAPS PharmSciTech. 7(3): E87-E92.(2006)
Bogner RH, Wilkosz MF. Fast-dissolving tablets.US pharmacist. 27 (03): 34-43.(2002)
Sharma G, Pawar VK, Garg G, Awasthi R, Kulkarni GT. Taste masking of promethazine hydrochloride using eudragit E100 via solid dispersion technique to develop fast disintegrating tablets. Der Pharmacia Lettre. 2010; 2(3): 83-9437. Amin AF, Shah TJ, Bhadani MN, Patel MM.
Emerging trends in the development of orally disintegrating tablet technology. Pharmaceutical Reviews 2006;4(1)[citied 2010 Mar 10]. Available form http://www.pharminfo.net/review/emerging-trends-development-orally-disintegration-tablet-technology
Jeong SH, Takaishi Y, Fu Y, Park K. Materials properties for making fast dissolving tablet dissolving Method. J Mater Chem. 18: 3527-3535.(2008)
Mizumoto T, Masuda Y, Kajiyama A, Yanagisawa M, Nyshadham JR. Tablets quickly disintegrating in the oral cavity and process for producing the same. United States patent US 6589554. July 8.(2003)
U. Vollmer, P. Galfetti, Drug. Dev. Report., 64-67(2006)
Suresh B, Rajendar KM, Ramesh G, Yamsani MR. Orodispersible tablets: An overview. Asian J Pharm 2:2-11.(2008)
Kancke J. Dissolution testing of orally disintegrating tablets. Disso Tech 2003;10:6-8.
Wehling F, Schuehle S, Madamala N. Effervescent dosage form with microparticles. US Patent 5,178,878, January 12, (1993)
Katzner L, Jones B, Khattar J, Kosewick J. Blister package and packaged tablet. US Patent 6,155,423, De-cember 5, (2000)
Khankari R, Hontz J, Chastain S, Katzner L. Rapidly dissolving robust dosage form. US Patent 6,024,981, February 15, (2000)
Yamanouchi Pharmaceutical Co. Press release: Open Yamanouchi Shaklee Pharma Research Center at Stanford Research Park, November 24, (1997)
Mizumoto T, Masuda Y, Fukui M. Intrabuccally dissolving compressed molding and production process thereof. U.S. Patent 5,576,014. November 19, (1996)
Pebley WS, Jager NE, Thompson SJ. Rapidly Disintegrating Tablets. US Patent 5,298,261, March 29, (1994)
Cremer K. Fast dissolving technologies in detail: Orally disintegrating dosage forms. Pharma Concepts, Humberg, Germany, GmbH and Co. KG; p. 62-97.(2001)
Jeong SH, Fu Y, Park K. Frosta: A new technology for making fastmelting tablets. Expert Opin Drug Deliv 2005;2:1107-16. 101. Laboratoire L. Galenic form for oral administration and its method of preparation by lyophilization of an oil-in-water emulsion. Eur Pat 0,159,237,(1985)
Kovacic M, Milovac J, Cvelbar P, Stalc A, TrostZ, Kopitar Z. Dispersible cimetidine tablets. US Patent 5,069,910; (1991)
Published
How to Cite
Issue
Section
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright © Author(s) retain the copyright of this article.
